Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 7/20 | 0.57 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28418862 | 0.94 | MGLL (0.54) | MGLLTLR9HDAC3HDAC4HDAC1 | |
| SCHEMBL5717701 | 0.83 | NR1H3 (0.63) | HDAC3MAPK1ADRA1AHDAC4SLC6A3 | |
| SCHEMBL722567 | 0.82 | MGLL (0.51) | MGLLTLR9HDAC3HDAC1HDAC2 | |
| Hydrochloric Acid SCHEMBL562848 | 0.81 | MGLL (0.50) | MGLLTLR9HDAC3HDAC1HDAC2 | |
| SCHEMBL8352899 | 0.81 | MGLL (0.77) | MGLLTLR9ALDH1A1HSP90AA1PKM | |
| SCHEMBL4957966 | 0.80 | MGLL (0.65) | MGLLTLR9ALDH1A1HSP90AA1PKM | |
| SCHEMBL8612834 | 0.79 | MGLL (0.59) | MGLLTLR9ALDH1A1HSP90AA1PKM | |
| SCHEMBL3873448 | 0.79 | MGLL (0.73) | MGLLTLR9ALDH1A1NR1H2NR1H3 | |
| SCHEMBL28019596 | 0.78 | MEN1 (0.37) | MGLLTLR9HDAC3MAPK1ADRA1A | |
| SCHEMBL3879458 | 0.78 | MGLL (0.71) | MGLLTLR9ALDH1A1NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2410991-A1 | ORALLY BIOAVAILABLE LIPID-BASED CONSTRUCTS | SDG, INC. (an Ohio Corporation ) (US) | 2012-02-01 | — | — | EP | claimed |
| EP-0895082-B1 | Bubble jet method for spotting probes on a solid support and method of manufacturing probe arrays. | CANON KK (JP) | 2003-09-24 | — | — | EP | claimed |
| EP-3270954-A1 | A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST | Amal Therapeutics SA (CH) | 2018-01-24 | — | — | EP | disclosed |
| EP-3270955-A1 | A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF COLORECTAL CANCER | Amal Therapeutics SA (CH) | 2018-01-24 | — | — | EP | disclosed |
| EP-2406630-B1 | IMMUNOASSAYS EMPLOYING NON-PARTICULATE CHEMILUMINESCENT REAGENT | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2018-01-17 | — | — | EP | disclosed |
| US-9720004-B2 | Immunoassays employing non-particulate chemiluminescent reagent | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2017-08-01 | — | — | US | disclosed |
| WO-2016146262-A1 | A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST FOR TREATMENT OF COLORECTAL CANCER | AMAL THERAPEUTICS SA (CH) | 2016-09-22 | — | — | WO | disclosed |
| WO-2016146143-A1 | CELL PENETRATING PEPTIDES AND COMPLEXES COMPRISING THE SAME | AMAL THERAPEUTICS SA (CH) | 2016-09-22 | — | — | WO | disclosed |
| WO-2016146260-A1 | A NOVEL COMPLEX COMPRISING A CELL PENETRATING PEPTIDE, A CARGO AND A TLR PEPTIDE AGONIST | AMAL THERAPEUTICS SA (CH) | 2016-09-22 | — | — | WO | disclosed |
| CN-105960265-A | Method for treating wound healing using chemically modified oligonucleotides | 阿克赛医药公司 | 2016-09-21 | — | — | CN | disclosed |
| US-20160231336-A1 | IMMUNOASSAYS EMPLOYING NON-PARTICULATE CHEMILUMINESCENT REAGENT | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2016-08-11 | — | — | US | disclosed |
| CN-102348980-B | Immunoassays employing non-particulate chemiluminescent reagent | SIEMENS HEALTHCARE DIAGNOSTICS | 2015-05-27 | — | — | CN | disclosed |
| WO-2011041003-A9 | COMPOSITIONS AND METHODS FOR PREPARING STAPHYLOCOCCUS AUREUS SEROTYPE 5 AND 8 CAPSULAR POLYSACCHARIDE CONJUGATE IMMUNOGENIC COMPOSITIONS | WYETH LLC (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2011041003-A2 | COMPOSITIONS AND METHODS FOR PREPARING STAPHYLOCOCCUS AUREUS SEROTYPE 5 AND 8 CAPSULAR POLYSACCHARIDE CONJUGATE IMMUNOGENIC COMPOSITIONS | WYETH LLC (US) | 2011-04-07 | — | — | WO | disclosed |
| WO-2010104683-A1 | IMMUNOASSAYS EMPLOYING NON-PARTICULATE CHEMILUMINESCENT REAGENT | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2010-09-16 | — | — | WO | disclosed |
| US-5686071-A | Polymer affinity system for the delivery of cytotoxic material and other compounds to sites of disease | PER IMMUNE HOLDINGS, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| WO-1996039124-A1 | POLYMER AFFINITY SYSTEMS FOR THE DELIVERY OF CYTOTOXIC MATERIALS AND OTHER COMPOUNDS TO SITES OF DISEASE | AKZO NOBEL N.V. (NL) | 1996-12-12 | — | — | WO | disclosed |
| US-4536391-A | REACTING A PLASMIN HEAVY CHAIN WITH UROKINASE IN THE PRESENCE OF A COUPLING AGENT | OTSUKA PHARMACEUTICAL CO. (JP) | 1985-08-20 | — | — | US | disclosed |
| EP-0109653-A2 | Process for preparing urokinase complex | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1984-05-30 | — | — | EP | disclosed |